CAS: 114312-57-1; Ethyl 3-Fluoro-2-Methylbenzoate

该化合物是一种含分子式C10H11FO2的氟芳酯,该化合物的特点是三位置用氟原子取代苯甲酸酯核心,二位置用乙醇浸泡的甲基组,其结构特性使它成为有机合成中的宝贵中间体,特别是在制药和农用化学应用中.氟氨替代会增强代谢稳定性和生物活性分子的紧合性,而乙酯组则提供多种用途,供进一步衍生.该化合物的特点是高纯度和一贯性能,适合需要精确氟化建筑块的研究和工业规模流程.

结构式图片

相似化合物

147624-13-3 699-90-1 500912-13-0

上下游产品

CAS号699-90-1 3-氟-2-甲基苯甲酸 | CAS号75-03-6 碘乙烷

合成工艺路线路线简述

    📜3-氟-2-甲基苯甲酸 反应生成3-氟-2-甲基苯甲酸乙酯
    参考文献:Novel Cyclic Amide Derivatives
    标题:Novel Cyclic Amide Derivatives
    摘要:以下公式(i)表示的新化合物作为sigma受体/结合位点的配体,并包括作为活性成分的药物: 其中x代表烷基,芳基,杂环基或类似基团;Q代表由-ch 2-,-co-,-o-,-ch(Or 7 )-或类似基团表示的基团,其中r 7 代表氢原子,烷基或类似基团;N代表从0到5的整数;R 1 和r 2 各自代表氢原子,烷基或类似基团;B代表以下任一基团: 其中r 3,R 4,R 5 和r 6 各自代表氢原子,卤素原子,烷氧基或类似基团;M代表1或2;以及: 代表芳香杂环环.

    海关参考信息

    专利信息


    专利号:WO-9314086-A1
    优先权日:1992-01-17
    标 题 :Substituted 1-isoquinolone derivatives as angiotensin ii antagonists
    发明人:FISHER LAWRENCE E; CAROON JOAN M; STABLER STEPHEN R; CLARK ROBIN D
    权利人:SYNTEX INC
    摘要:1-Isoquinolone derivatives and related compounds according to formula (I) wherein, Y is selected from the group consisting of H, OH, lower alkoxy, and halo; X is selected from the group consisting of H, lower alkyl acid, lower alkyl ester, and lower alkyl; and R1 is selected from the group consisting of H, alkenyl, lower alkyl, lower cycloalkyl, unsubstituted or substituted 3-spiro-1H-indane of structure (II) wherein R2 is H, OH, lower alkyl, lower alkoxy or halo, and 3-spiro-cycloalkyl of structure (III) wherein n is an integer from zero to six, provided that when R1 is spiro- X is H, or a pharmaceutically acceptable salt thereof, with the proviso that when R1 is spiro-, X is H, and when R1 is H, alkenyl, lower alkyl or lower cycloalkyl substituted at the 3-position of the isoquinolone moiety and X is H or lower alkyl, the (2'-1H--tetrazol-5-yl)biphenyl-4'-ylmethyl group cannot be at the 2(N) position, are useful as angiotensin II receptor antagonists. Also disclosed are methods of synthesis, intermediates, pharmaceutical formulations and methods of treatment.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知